Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Phreesia Inc (NY: PHR )

18.47 +0.18 (+0.98%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 241,118
Open 18.39
Bid (Size) 16.36 (2)
Ask (Size) 26.80 (1)
Prev. Close 18.29
Today's Range 18.22 - 18.50
52wk Range 14.28 - 29.16
Shares Outstanding 50,519,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Phreesia Sets Release Date for Fiscal Third Quarter 2025 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Achieves Oracle Validated Integration With Oracle Health EHR Expertise for Delivering Proven, Repeatable Integration
From Phreesia, Inc.
Via Business Wire

Performance

YTD
-19.49%
-19.49%
1 Month
-16.76%
-16.76%
3 Month
-18.63%
-18.63%
6 Month
-18.56%
-18.56%
1 Year
+19.32%
+19.32%

More News

Read More
Phreesia Joins the Network Advertising Initiative as a Member, Demonstrating Ongoing Commitment to Industry-Leading Privacy Practices
From Phreesia, Inc.
Via Business Wire
The Latest Analyst Ratings For Phreesia
Via Benzinga
A Glimpse Into The Expert Outlook On Phreesia Through 4 Analysts
Via Benzinga
A Glimpse Into The Expert Outlook On Phreesia Through 6 Analysts
Via Benzinga
Phreesia and Ad Council Partnership Yields High Patient Engagement in 3 Mental Health Awareness Campaigns
From Phreesia, Inc.
Via Business Wire
Phreesia Secures New Contract With CMS as Report Shows Gains in Patient Activation in First Year of Kidney Care Choices (KCC) Model
From Phreesia, Inc.
Via Business Wire
New Research Shows Point-of-Care Patient Outreach Supports Vaccine Confidence and Adoption
From Phreesia, Inc.
Via Business Wire
Assessing Phreesia: Insights From 12 Financial Analysts
Via Benzinga
CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence
From Phreesia, Inc.
Via Business Wire
Phreesia Announces Second Quarter Fiscal 2025 Results
From Phreesia
Via Business Wire
Phreesia and American Academy of Pediatrics Join in Campaign to Increase Childhood MMR Vaccination
From Phreesia
Via Business Wire
Bob Glazer Joins Phreesia as Strategic Advisor
From Phreesia
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Helen of Troy, Owens & Minor, Salesforce, and Phreesia and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Phreesia Sets Release Date for Fiscal Second Quarter 2025 Results
From Phreesia, Inc.
Via Business Wire
Phreesia Now Available on Oracle Healthcare Marketplace
From Phreesia
Via Business Wire
Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga
PHREESIA ALERT: Bragar Eagel & Squire, P.C. is Investigating Phreesia, Inc. on Behalf of Phreesia Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Phreesia, Inc. (PHR)
From Kirby McInerney LLP
Via Business Wire
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
From Phreesia
Via Business Wire
Phreesia, Inc. (PHR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.